Study to Determine Effective Dosing of Fondaparinux in Obese Persons
Status:
Withdrawn
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
This is a prospective open-label study comparing two dosing regimens of fondaparinux, which
is used to prevent deep vein thrombosis, in morbidly obese volunteers.